Paradigm Therapeutics, Inc.

Our mission is to improve the lives of patients experiencing serious, life-threatening diseases by the discovery, development and delivery of innovative therapies. Our lead therapy, Zorblisa™, is a proprietary topical therapy being developed for the treatment of patients with Epidermolysis Bullosa (EB).